Gulf International Bank (UK)’s Neurocrine Biosciences NBIX Stock Holding History

Gulf International Bank (UK)’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28M	Sell	7,595 -102	-1%	-$15.1K	0.03%	472
2026 Q1	$1.01M	Buy	7,697 +1,907	+33%	+$253K	0.02%	508
2025 Q4	$821K	Hold	5,790	–	–	0.03%	484
2025 Q3	$813K	Sell	5,790 -160	-3%	-$21.7K	0.03%	486
2025 Q2	$747K	Hold	5,950	–	–	0.03%	493
2025 Q1	$658K	Sell	5,950 -1,745	-23%	-$221K	0.02%	530
2024 Q4	$1.05M	Hold	7,695	–	–	0.03%	476
2024 Q3	$886K	Sell	7,695 -373	-5%	-$51.1K	0.02%	514
2024 Q2	$1.11M	Hold	8,068	–	–	0.03%	463
2024 Q1	$1.11M	Hold	8,068	–	–	0.03%	477
2023 Q4	$1.06M	Sell	8,068 -1,048	-11%	-$121K	0.03%	472
2023 Q3	$1.02M	Sell	9,116 -763	-8%	-$80.3K	0.03%	479
2023 Q2	$931K	Sell	9,879 -2,821	-22%	-$276K	0.02%	540
2023 Q1	$1.28M	Sell	12,700 -720	-5%	-$74.9K	0.03%	514
2022 Q4	$1.6M	Hold	13,420	–	–	0.03%	508
2022 Q3	$1.43M	Hold	13,420	–	–	0.03%	519
2022 Q2	$1.32M	Hold	13,420	–	–	0.02%	540
2022 Q1	$1.26M	Hold	13,420	–	–	0.02%	568
2021 Q4	$1.14M	Hold	13,420	–	–	0.02%	592
2021 Q3	$1.29M	Hold	13,420	–	–	0.02%	608
2021 Q2	$1.31M	Hold	13,420	–	–	0.02%	619
2021 Q1	$1.3M	Sell	13,420 -6,300	-32%	-$661K	0.02%	607
2020 Q4	$1.89M	Sell	19,720 -200	-1%	-$19.3K	0.02%	561
2020 Q3	$1.92M	Hold	19,920	–	–	0.03%	503
2020 Q2	$2.43M	Hold	19,920	–	–	0.04%	434
2020 Q1	$1.72M	Hold	19,920	–	–	0.03%	456
2019 Q4	$2.14M	Buy	+19,920	New	+$2.09M	0.03%	496

Other funds holding NBIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Gulf International Bank (UK)'s NBIX Position: Q2 2026 in Review

Gulf International Bank (UK) reduced its Neurocrine Biosciences (NBIX) stake by 1.3% in Q2 2026, selling an estimated $15.1K and leaving 7,595 shares worth $1.28M. The position accounts for 0.03% of the portfolio, ranked #472.

Gulf International Bank (UK) first reported a position in NBIX in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.43M in Q2 2020. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

Gulf International Bank (UK) held 7,595 shares of Neurocrine Biosciences worth $1.28M as of Q2 2026.
Gulf International Bank (UK) sold 102 Neurocrine Biosciences shares in Q2 2026, an estimated $15.1K.
Neurocrine Biosciences made up 0.03% of Gulf International Bank (UK)'s portfolio in Q2 2026, its #472 holding.
Gulf International Bank (UK) first reported a position in Neurocrine Biosciences in Q4 2019 and has held it in 27 quarters since.
Gulf International Bank (UK)'s Neurocrine Biosciences position peaked at $2.43M in Q2 2020.
781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q2 2026, filed 13 Aug 2026.